Carlsbad’s Ionis gets $25M upfront for licensing hepatitis B drugs to GSK August 27, 2019 sandiegobiotech News Comments Off on Carlsbad’s Ionis gets $25M upfront for licensing hepatitis B drugs to GSK Hundreds of millions more possible to Ionis if drugs reach milestones